Sveriges mest populära poddar
MDS Podcast
Vetenskap

A post-hoc analysis of the Prasinezumab trial in early Parkinson's disease

15 juli 2024
Dr. Gennaro Pagano discusses the findings of the post-hoc analysis of the PASADENA trial, a study using the monoclonal antibody Prasinezumab directed at aggregated α-synuclein, where motor progression trajectories differed between active and placebo groups. Read article »

Fler avsnitt av MDS Podcast

Visa alla avsnitt av MDS Podcast
Hot Topic: Argentine tango in the rehabilitation of persons with Parkinson's disease
Blocking alpha-synuclein propagation with perampanel
End of life preferences of people with Parkinson's disease
Quality of life in Parkinson’s disease
New data to reframe the risks of DBS surgery for patients and providers
Ataxia Series: Treating cerebellar ataxia in 2026 - What's new?
Prodromal autonomic dysfunction in Lewy body diseases
Ataxia Series: Beyond the cerebellum - Non-motor features and multisystem care in genetic ataxias
Modulating the peripheral immune response: LRRK2 and GBA1 mutations
Ataxia Series: Neuroimaging patterns not to miss in ataxia

MDS Podcast med International Parkinson and Movement Disorder Society finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.